<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39097401</PMID><DateRevised><Year>2024</Year><Month>08</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1468-2044</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Aug</Month><Day>03</Day></PubDate></JournalIssue><Title>Archives of disease in childhood</Title><ISOAbbreviation>Arch Dis Child</ISOAbbreviation></Journal><ArticleTitle>Performance of blood enterovirus and parechovirus polymerase chain reaction testing in young febrile infants: a prospective multicentre observational study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">archdischild-2024-327367</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/archdischild-2024-327367</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To analyse the performance of blood enterovirus and parechovirus PCR testing (ev-PCR) for invasive bacterial infection (IBI) (isolation of a single bacterial pathogen in a blood or cerebrospinal fluid culture) when evaluating well-appearing infants ≤90 days of age with fever without a source (FWS).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We describe the well-appearing infants ≤90 days of age with FWS and normal urine dipstick. We performed a prospective, observational multicentre study at five paediatric emergency departments between October 2020 and September 2023.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 656 infants were included, 22 (3.4%) of whom were diagnosed with an IBI (bacteraemia in all of them and associated with meningitis in four). The blood ev-PCR test was positive in 145 (22.1%) infants. One patient with positive blood ev-PCR was diagnosed with an IBI, accounting for 0.7% (95% CI 0.02 to 3.8) compared with 4.1% (95% CI 2.6 to 6.2) in those with a negative test (p=0.04). All four patients with bacterial meningitis had a negative blood ev-PCR result. Infants with a positive blood ev-PCR had a shorter hospital stay (median 3 days, IQR 2-4) compared with 4 days (IQR 2-6) for those with negative blood ev-PCR (p=0.02), as well as shorter duration of antibiotic treatment (median 2 days, IQR 0-4 vs 2.5 days, IQR 0-7, p=0.01).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Young febrile infants with a positive blood ev-PCR are at a low risk of having an IBI. Incorporating the blood ev-PCR test into clinical decision-making may help to reduce the duration of antibiotic treatments and length of hospital stay.</AbstractText><CopyrightInformation>© Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Alonso-Cadenas</LastName><ForeName>Jose Antonio</ForeName><Initials>JA</Initials><Identifier Source="ORCID">0000-0002-7648-1336</Identifier><AffiliationInfo><Affiliation>Emergency Department, Hospital Infantil Universitario Niño Jesús, Madrid, Spain jalonsocadenas@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Investigacion del Hospital de La Princesa, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Velasco</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-0073-2650</Identifier><AffiliationInfo><Affiliation>Pediatric Emergency Department, Hospital Universitari Parc Tauli, Sabadell, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clerigué Arrieta</LastName><ForeName>Nuria</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Navarre Hospital Complex, Pamplona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amasorrain Urrutia</LastName><ForeName>Jone</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hospital of Mendaro, Mendaro, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suarez-Bustamante Huélamo</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Emergency Department, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mintegi</LastName><ForeName>Santiago</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Pediatric Emergency Department, Hospital Universitario Cruces, Barakaldo, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of the Basque Country, Bilbao, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gomez</LastName><ForeName>Borja</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0001-6542-4494</Identifier><AffiliationInfo><Affiliation>Pediatric Emergency Department, Hospital Universitario Cruces, Barakaldo, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Arch Dis Child</MedlineTA><NlmUniqueID>0372434</NlmUniqueID><ISSNLinking>0003-9888</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">emergency care</Keyword><Keyword MajorTopicYN="N">paediatric emergency medicine</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>4</Day><Hour>13</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>4</Day><Hour>13</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>3</Day><Hour>21</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39097401</ArticleId><ArticleId IdType="doi">10.1136/archdischild-2024-327367</ArticleId><ArticleId IdType="pii">archdischild-2024-327367</ArticleId></ArticleIdList></PubmedData></PubmedArticle>